the best CEO on the planet can not foresee or ensure a positive clinical and/or regulatory outcome. These are cutting edge tests, with unknown outcomes. Sure, they have hope and opinion on what the outcome is, as too these are backed by limited data on small previous tests, where somewhat logical next step assumptions are taken.
I don’t want you to hold back on your comments, just know, some of this is a flip of a coin stuff. Such is the nature of bio’s and the rewards are staggering if the flips goes our way.
at this stage of the game, SI is not going anywhere.
MSB Trading 2021 - paradigm shift, page-722
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |